Unknown

Dataset Information

0

MicroRNA-214-3p targets the PLAGL2-MYH9 axis to suppress tumor proliferation and metastasis in human colorectal cancer.


ABSTRACT: Evidence has shown that microRNAs (miRNAs) participate in the progression of CRC. Previous studies have indicated that miR-214-3p is abnormally expressed in various malignant tumors. However, the biological function it plays in CRC and the potential mechanism are unclear. Here, we demonstrated that miR-214-3p was obviously downregulated in CRC. Moreover, we found a strong correlation between the miR-214-3p level and tumor size and lymphatic metastasis. Furthermore, when miR-214-3p was decreased by an Lv-miR-214-3p inhibitor, the proliferation and migration of SW480 and HCT116 cells were significantly increased. As expected, the ability of proliferation and migration was significantly suppressed when miR-214-3p was overexpressed in DLD1 cells. According to the dual-luciferase reporter results, PLAGL2 was found to be a direct downstream molecule of miR-214-3p. Chromatin immunoprecipitation (CHIP) confirmed that MYH9, a well-known cytoskeleton molecule in CRC, was a direct targeting gene of PLAGL2. Silencing PLAGL2 or MYH9 could reverse the effect of a miR-214-3p inhibitor on CRC cells. In summary, our studies proved that low expression of miR-214-3p and overexpression of downstream PLAGL2 in CRC indicated a poor prognosis. MiR-214-3p suppressed the malignant behaviors of colorectal cancer by regulating the PLAGL2/MYH9 axis. MiR-214-3p might be a novel therapeutic target or prognostic marker for CRC.

SUBMITTER: Zhou Z 

PROVIDER: S-EPMC7288958 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

MicroRNA-214-3p targets the PLAGL2-MYH9 axis to suppress tumor proliferation and metastasis in human colorectal cancer.

Zhou Zili Z   Wu Liang L   Liu Zhengyi Z   Zhang Xudan X   Han Shengbo S   Zhao Ning N   Bao Haijun H   Yuan Wenzheng W   Chen Jinhuang J   Ji Jintong J   Shu Xiaogang X  

Aging 20200515 10


Evidence has shown that microRNAs (miRNAs) participate in the progression of CRC. Previous studies have indicated that miR-214-3p is abnormally expressed in various malignant tumors. However, the biological function it plays in CRC and the potential mechanism are unclear. Here, we demonstrated that miR-214-3p was obviously downregulated in CRC. Moreover, we found a strong correlation between the miR-214-3p level and tumor size and lymphatic metastasis. Furthermore, when miR-214-3p was decreased  ...[more]

Similar Datasets

| S-EPMC5595136 | biostudies-literature
| S-EPMC4680391 | biostudies-literature
| S-EPMC8800331 | biostudies-literature
| S-EPMC8667113 | biostudies-literature
| S-EPMC8315017 | biostudies-literature
| S-EPMC7760887 | biostudies-literature
| S-EPMC4155808 | biostudies-other
| S-EPMC7477767 | biostudies-literature
| S-EPMC6382814 | biostudies-literature
| S-EPMC7753913 | biostudies-literature